http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MY-107001-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5fda88af8568138236da8625ae003e40
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-501
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
filingDate 1991-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30380b70921e81a42bf139916f9d47d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9dc87dfb5496d5f930acbfbacdab4cb3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a5a0dd7e9e98eacde7ec3f63eacce9a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_917be923b0f555686d41c80510f9ea69
publicationDate 1995-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MY-107001-A
titleOfInvention Pharmaceutical compounds.
abstract COMPOUNDS OF THE FORMULA (I) OR SALTS THEREOF, WHEREIN THE DOTTED LINE REPRESENTS A SINGLE OR DOUBLE BOND, R1 IS C1-4 ALKYL OR AMINO OPTIONALLY SUBSTITUTED BY A C1-4 ALKYL, C1-5 ALKANOYL OR BENZYL GROUP; R2,R3,R4 AND R5 ARE THE SAME OR DIFFERENT AND EACH IS SELECTED FROM HYDROGEN, PHENYL, HALO, NITRO, A GROUP S(O)N R8 WHEREIN N IS THE INTEGER O, 1 OR 2 AND R8 IS HALO OR IS C1-4 ALKYL OR A GROUP NR9R10 WHEREIN R9 AND R10 ARE BOTH HYDROGEN, A GROUP NR11R12 WHEREIN R11 AND R12 ARE THE SAME OR DIFFERENT AND EACH IS HYDROGEN OR C1-4 ALKYL, A GROUP OR13 WHEREIN R13 IS HYDROGEN OR C1-4 ALKYL OPTIONALLY SUBSTITUTED BY HALO; A C1-4 ALIPHATIC GROUP OPTIONALLY SUBSTITUTED BY A GROUP OR14 OR NR14R15 WHEREIN R14 AND R15 ARE THE SAME OR DIFFERENT AND EACH IS HYDROGEN OR C1-4 ALKYL; OR TWO OF R2 TO R5 ARE LINKED TOGETHER TO FORM A BENZO GROUP, OR ONE OF R2 TO R5 IS A GROUP -X-Y-R16 WHEREIN X IS CH2, NR17, CO OR S(O)M AND M IS O,1 OR 2 AND R17 IS HYDROGEN OR A C1-4 ALIPHATIC GROUP PROVIDED THAT X AND Y ARE ONLY THE SAME WHEN EACH IS CH2, OR -X-Y- IS A GROUP -O-, -NR17-, -CH=CH- OR -N=N- WHEREIN R17 IS AS HEREINBEFORE DEFINED, R16 IS A C1-4 ALIPHATIC GROUP OR A 5-OR 6- MEMBERED AROMATIC RING OPTIONALLY SUBSTITUTED BY A GROUP R18 AT A POSITION AT LEAST ONE CARBON ATOM REMOVED FROM THAT LINKED TO Y, THE 5-OR 6-MEMBERED RING BEING OPTIONALLY FURTHER SUBSTITUTED BY A HALO ATOM, AND R18 IS HALO, C1-4 ALKOXY, NITRO, NITRILE, C1-4 ALKY OPTIONALLY SUBSTITUTED BY HALO OR A GROUP COR19 WHEREIN R19 IS HYDROXY, C1-4 ALKOXY OR C1-6 ALKYL OPTIONALLY SUBSTITUTED BY ONE OR TWO CARBOXYL GROUPS OR C1-12 ESTERS THEREOF OR R19 IS A GROUP NR20R21 WHEREIN R20 ANS R21 ARE THE SAME OR DIFFERENT AND EACH IS HYDROGEN OR C1-4 ALKYL OPTIONALLY SUBSTITUTED BY HYDROXY OR R19 IS AN AMINO ACID GROUP OR AN ESTER THEREOF IN WHICH THE FIRST NITROGEN ATOM OF THE AMINO ACID GROUP MAY BE LINKED TO THE 5- OR 6- MEMBERED AROMATIC RING TO FORM A FURTHER 5- OR 6- MEMBERED HETEROCYCLIC RING OR R19 IS AN C2-3 ALKYLENE GROUP LINKED TO THE 5- OR 6- MEMBERED AROMATIC RING TO TO FROM A FURTHER 5- OR 6- MEMBERED RING; R6 AND R7 ARE THE SAME OR DIFFERENT AND EACH IS HYDROGEN, C1-4 ALKYL OPTIONALLY SUBSTITUTED BY HYDROXY OR C1-4 ALKOXY OR TOGETHER FORM A BENZO GROUP; PROVIDED THAT AT LEAST ONE OF R2 TO R7 IS OTHER THAN HYDROGEN AND THAT R4 IS NOT METHOXY WHEN R1 IS HYDROXY OR METHYL, ARE DISCLOSED AS PHARMACOLOGICAL AGENTS USEFUL IN THE TRETMENT OF TUMOURS. PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THE PREPARATION OF COMPOUNDS OF THE FORMULA (I) ARE ALSO DESCRIBED.
priorityDate 1990-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393787
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559484
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3609161
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155

Total number of triples: 44.